Hepato-Pancreato-Biliary Surgery and Liver Transplantation Unit, University of Modena and Reggio-Emilia, Modena, MO, Italy.
Int J Med Robot. 2019 Aug;15(4):e2004. doi: 10.1002/rcs.2004. Epub 2019 May 28.
Hepatocellular carcinoma (HCC) represents a leading cause of death in patients with cirrhosis. This review attempts to clarify the role of robotic surgery for HCC in terms of oncologic outcomes.
A systematic literature search was performed according to the PRISMA statement including papers comparing open, robotic, and laparoscopic approach for liver surgery. If more than one study was reported by the same institute, only the most recent or the highest quality study was included.
The literature search yielded 302 articles; titles and abstracts were reviewed for inclusion. Ten papers were finally included in this review for a total of 307 patients who underwent robotic resection for HCC.
Robotic liver resection for HCC is effective in terms of oncological results as compared with open and laparoscopic approach when performed in experienced centers and is accurate in terms of R0 rates and disease-free surgical margin.
肝细胞癌（HCC）是肝硬化患者死亡的主要原因。本综述旨在探讨机器人手术治疗 HCC 的肿瘤学结果。
根据 PRISMA 声明进行系统文献检索，纳入比较开腹、机器人和腹腔镜肝切除术的研究。如果同一机构报告了多项研究，则仅纳入最新或质量最高的研究。
文献检索得到 302 篇文章；对标题和摘要进行了评估以确定是否符合纳入标准。最终有 10 篇文章被纳入本综述，共有 307 例患者接受机器人肝切除术治疗 HCC。
在经验丰富的中心，与开腹和腹腔镜手术相比，机器人肝切除术治疗 HCC 在肿瘤学结果方面是有效的，在 R0 率和无疾病手术切缘方面是准确的。
